Full-Time

Senior External Data Specialist

Posted on 11/7/2025

eClinical Solutions

eClinical Solutions

201-500 employees

SaaS data management for clinical trials

No salary listed

Bengaluru, Karnataka, India

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Basic Science/Bachelor of Science degree in health-related field or an equivalent combination of education, training and directly related experience to successfully perform the key responsibilities of the job.
  • Excellent command of the English language (both written and verbal).
  • 5+ years’ experience or an equivalent combination of education and experience to successfully perform the key responsibilities of the job.
  • Ability to maintain confidentiality of data and information during interactions with staff at all levels.
  • Understanding of ICH/GCP guidelines, 21 CFR Part 11 and clinical trial methodology
  • Basic understanding of medical terminology
  • Excellent team player and collaborator
  • Ability to work independently and manage multiple projects.
  • Detail oriented, ability to multitask, with strong organizational skills.
  • Strong communication skills.
  • Knowledge of clinical data management processes and vendor data processing
  • Familiarity with various 3rd party vendors and data transfers.
  • Understands a variety of external data types and methodologies.
  • Strong leadership and mentoring skills.
  • Considerable experience within the CRO or pharmaceutical industry.
  • Proficiency in Microsoft Office Applications
  • Accurate keyboarding skills
  • Demonstrated computer literacy
  • Clinical Data Management System(s) knowledge, including Electronic Data Capture system(s)
Responsibilities
  • Act as primary study contact, subject matter expert (SME) and liaison for external data and local lab processing on assigned studies for internal and external stakeholders.
  • Communicate to Clinical Data Manager, study team, and/or Manager, External Data problems involving local lab data point issues and validation issues.
  • Communicate to vendors and client issues involving external data transfers, data point issues and validation issues.
  • Perform QC of laboratory normal ranges prior to entry to ensure documents received are ICH/CGP compliant and accurate.
  • Perform Lab Normal Range data entry and/or QC, meeting processing deliverables on time and with quality.
  • Review study protocols and local lab and external data eCRF design in start-up, providing recommendations and insights into best approach for data aggregation and capture.
  • Ensure clinical database supports data requirements and is in alignment with external vendor data.
  • Perform QC of external data test transfers for acceptance.
  • Maintain data transfer agreement set-up logs, reconciliation logs and/or change logs.
  • Verify the normal ranges are properly linked to the patient results in the local lab data collection module of the database.
  • Review external vendor data and/or local laboratory data listings via elluminate and issue queries or communicate data issues to internal and/or external team members.
  • Review and provide input to DMP, IDROP and CCG to ensure local lab normal range and/or external data process for assigned study is accurately documented.
  • Perform local lab and external vendor associated study start-up and build activities.
  • Perform IST activities for local lab normal range population.
  • Develop the local lab and external data exception listing specifications and QC the output for movement to production.
  • Drive the set-up and implementation of external vendor data transfer agreements and specifications, working closely with the client, vendors, and functional teams.
  • Provide study specific local lab and/or external vendor data driven metrics to Clinical Data Management, Client and/or Project Management.
  • Report client and/or study level local lab and/or external vendor data driven units to Project Management for scope monitoring.
  • Attend internal and external study team calls, as needed, for support of study specific local lab and external vendor data processes.
  • Identify and recommend process improvements, working with functional team leads and management for developing, reviewing, and implementing processes and guidelines for external data and local lab data processing.
  • Support management for reporting of external data and local lab KPI’s and performance metrics.
  • Work closely with cross-functional teams on study reporting and data trending via clinical data analytics technologies for local laboratory and/or external vendor data to proactively identify and mitigate risks.
  • Contribute to digital transformation in external data management, leveraging emerging technologies to streamline process, ensure compliance and stay at the forefront of industry advancements.
  • Utilize technology including AI ML and advanced analytics to perform real time monitoring to proactively identify and address data discrepancies, ensuring accuracy, integrity, and quality of various external and local lab data.
  • Facilitate external and local lab data cross-functional team training.
  • Other duties as assigned.

eClinical Solutions provides data management and analytics for clinical trials in the biopharma sector. Its platform, elluminate, is a SaaS that integrates data from many sources to enable comprehensive statistical analyses and operational insights, supported by professional services. The product works by centralizing diverse trial data in a single system, allowing users to run analyses, generate insights, and collaborate across teams, with scalability and adaptability to program changes. Compared with competitors, the company combines a specialized, data-centric platform with ongoing consulting services, offering end-to-end data integration, analytics, and operational support that helps clients manage large amounts of trial data and adapt quickly. The goal is to accelerate the development of new treatments and improve trial efficiency by modernizing data management and enabling faster, data-driven decisions.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Mansfield, Ohio

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Added 20+ clients in 2025, serving 18 of top 50 pharma firms.
  • argenx expanded elluminate adoption March 2026 for data efficiency.
  • GI Partners investment fuels C-suite growth with Whitsell and Mallarapu.

What critics are saying

  • Medidata Rave's 70% market share locks top biopharma, demoting eClinical.
  • Veeva Vault erodes CRO base, cuts 20-30% subscription revenue in 6-12 months.
  • Open-source AI enables in-house RBQM, slashes SaaS fees by 40%.

What makes eClinical Solutions unique

  • elluminate platform integrates AI agents for real-time data review automation.
  • RBQM traceability with RACT ensures ICH E6 R(3) compliance and audit readiness.
  • Bidirectional Snowflake integration streamlines clinical data architecture.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

1%
Bio-IT World
Mar 23rd, 2026
eClinical Solutions elluminate(R) platform supports argenx to enhance data oversight and efficiency.

eClinical Solutions elluminate(R) platform supports argenx to enhance data oversight and efficiency. March 23, 2026 March 24, 2026, BOSTON - eClinical Solutions LLC, a global provider of digital clinical software and services, today announced that argenx SE, a global immunology company, is expanding adoption of the elluminate Clinical Data Cloud(R) to improve and enhance clinical data processes. The elluminate platform is designed to improve access to and analysis of clinical trial data across sources with a central source of communication for clinical data, including Data Central for collaborative data review across sources, Clinical Analytics for self-service data visualization and analysis, Sample Management Analytics for tracking of external data, and Protocol Deviations for trial oversight and compliance. elluminate eIQ Review, an AI-enabled data review and query automation system, and machine learning (ML)-driven Audit Trail Review integrates more advanced capabilities. This approach aims to help reduce cycle times through improved data quality. "We're excited to continue supporting argenx's commitment to future-proofing clinical trials with a modern data infrastructure," says Raj Indupuri, CEO and co-founder at eClinical Solutions. "The expanded collaboration will aid argenx in innovating their data operations, enhance collaboration and data quality, and accelerate time to market in support of their vision to reach more patients with breakthrough science." For more information on eClinical Solutions' AI-enabled elluminate platform, click here. About eClinical Solutions LLC eClinical Solutions' industry-leading clinical data intelligence platform, elluminate(R), and biometrics services experts help biopharma researchers at large, mid-size, and emerging life sciences organizations develop tomorrow's breakthroughs with today's resources. eClinical is a privately-held, purpose-driven company with a global workforce and winner of the 2025 Top Workplace USA Award: Remote Work, the 2025 Top Workplaces Culture Excellence Award: Work-Life Flexibility, and Great Place To Work(R) India Certification(TM). Learn more at http://www.eclinicalsol.com/ and follow eClinical Solutions on LinkedIn.

eClinical Solutions
Mar 12th, 2026
eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer

eClinical Solutions appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer. Press Releases Released: March 12, 2026 Supporting 18 of the top 50 pharmaceutical companies in the world with its industry-leading clinical data intelligence platform, the company eyes its next phase of growth with expanded C-suite March 12, 2026, BOSTON - eClinical Solutions LLC, a global provider of digital clinical software and services, today announced two additions to its C-suite with the hiring of Lauren Whitsell as Chief Operating Officer and appointment of Venu Mallarapu as Chief Transformation and AI Officer. The news comes following a growth investment from GI Partners, signaling strong momentum as the company deepens its product roadmap, further embedding AI and risk-based capabilities, and ensures future-ready trials to drive tomorrow's breakthroughs. Whitsell brings over two decades of experience across technology and healthcare with a proven track record of operational leadership, scaling companies and systems, and driving improved performance. Whitsell holds a Bachelor of Business Administration in MIS & Mathematics from University of Notre Dame and a Master of Business Administration from Northwestern University's Kellogg School of Management. She joins eClinical Solutions after serving as Chief Product and Operations Officer at STARLIMS where she led an organization focused on improving product development, implementation, and support of the STARLIMS solution for customers globally. Prior to STARLIMS, she led operations at Appriss Health and Appriss Insights, before being acquired by Equifax Workforce Solutions. "As eClinical Solutions focuses on innovating the future of clinical trial automation, scaling operations and driving internal efficiencies that mirror the expectations of our customers is equally critical to maintaining our market-leading capabilities," said Lauren Whitsell, COO of eClinical Solutions. "I'm passionate about technology, efficiency, and growth that will support the end-to-end clinical research lifecycle." In her role, Whitsell will focus on executive leadership for all post-sale functions for the business, including professional services, implementation, support, training, adoption, and offshore operations, while championing a culture of high-quality customer service and operational excellence across the company. In his new role, Mallarapu will drive the company's AI-first strategy, ensuring technology and processes optimize AI and automation to support workforce transformation and deliver exceptional customer experience. Building on his tenure as Executive Vice President of Global Operations for eClinical Solutions, Mallarapu takes on expanded strategic responsibility. Under his leadership, eClinical Solutions' global delivery organization and partner ecosystem have scaled significantly, supporting the company's growth across 18 of the top 50 pharmaceutical companies worldwide. Together, the new appointees will support the long-term strategic pillars of the company amid rapid growth and scaling operations. "Over the last four years, I've seen firsthand how eClinical Solutions has evolved elluminate(R) to an end-to-end clinical data intelligence platform to achieve trial outcomes," said Venu Mallarapu, Chief Transformation and AI Officer at eClinical Solutions. "eClinical is shifting clinical data chaos into actionable decisions for biopharma leaders, especially in expanding our elluminate agents, which are fueled by data products with shared context and workflows and a foundation with grounding guardrails and policies. Internally, we are taking a similar approach to unite intentional AI strategy and innovation for operational transformation. I'm focused on building the AI and operational foundation that sets the standard for how clinical data companies run and win in the next decade." "When eClinical Solutions was founded in 2012, we had a vision to help solve the industry's clinical data challenges. We leveraged our deep expertise in clinical data and biometrics services to evolve the elluminate platform, enhanced by collaborations - including ZS and Snowflake - and driven by our expanding C-suite of experts," said Raj Indupuri, CEO and co-founder of eClinical Solutions. "Our infrastructure continues to scale, from deploying AI agents to enabling integrated risk management. We are committed to delivering value for biopharma and CRO organizations in alignment with our founding vision to help the life sciences industry reduce cycle times, improve quality, and bring breakthrough therapies to patients faster. I look forward to the support Lauren and Venu provide as we continue in our growth journey." About eClinical Solutions LLC. eClinical Solutions' industry-leading clinical data intelligence platform, elluminate(R), and biometrics services experts help biopharma researchers at large, mid-size, and emerging life sciences organizations develop tomorrow's breakthroughs with today's resources. eClinical is a privately-held, purpose-driven company with a global workforce and winner of the 2025 Top Workplace USA Award: Remote Work, the 2025 Top Workplaces Culture Excellence Award: Work-Life Flexibility, and Great Place To Work(R) India Certification(TM). Learn more at www.eclinicalsol.com and follow eClinical Solutions on LinkedIn.

The AI Journal Ltd
Feb 26th, 2026
eClinical Solutions Highlights 2025 Achievements and Announces Latest Innovations to Accelerate and Future-Proof Clinical Trials

eClinical Solutions highlights 2025 achievements and announces latest innovations to accelerate and future-proof clinical trials. Working with top global pharmaceutical sponsors, company doubles down on agentic AI and RBQM investments to bend the clinical development efficiency curve BOSTON-(BUSINESS WIRE)-eClinical Solutions LLC, a global provider of digital clinical software and services, today announced 2025 milestones along with new 2026 innovation to support the end-to-end clinical research lifecycle, bringing breakthrough therapies to patients faster. Last year the company added over 20 net new customers to its portfolio of biopharma and CRO clients, which now includes 18 of the top 50 pharmaceutical companies in the world, supporting clinical trial leaders with an AI-first, risk-based approach. Notably, eClinical Solutions focused on evolving elluminate as a clinical data intelligence platform to improve trial efficiency, debuting elluminate agents. The agents are fueled by data products with shared context and workflows with agentic, assistive, and task-oriented AI, and a data foundation with grounding guardrails and policies. Additionally, the company launched a digitized Integrated Data Review Plan (IDRP), positioning eClinical Solutions as the first company to centralize digital data review within a single platform, and announced an industry collaboration with ZS, pairing eClinical Solutions' elluminate RBQM (risk-based quality management) technology with ZS' RBQM consulting and custom-built solution expertise to create a unified integrated quality risk management (IQRM) experience for sponsors. Other key company highlights from 2025 included industry recognition in Everest Group's Tech Provider Spotlight: Risk-Based Quality Management (RBQM) report, highlighting eClinical Solutions' elluminate RBQM capabilities. eClinical Solutions also won the 2025 Top Workplace USA Award: Remote Work and the 2025 Top Workplaces Culture Excellence Award: Work-Life Flexibility, for the fourth consecutive year. Finally, the Society for Clinical Data Management (SCDM) awarded eClinical Solutions with the SCDM Innovation Award for Advancements in Health Insight Generation and elected Dawn Kaminski, Vice President of Business Development Operations at eClinical Solutions as Executive Secretary of the SCDM Board for 2026. Building on 2025 momentum, the company has unveiled new updates to the elluminate platform this year aimed at supporting sponsors' objectives - from ensuring ease of compliance with the revised ICH E6 R(3) guidelines to expanding agentic AI efficiencies: * Agentic data review automation: The Explain Agent in Data Central uses clinical data and protocol-aware intelligence to interpret charts in real time, highlight meaningful patterns, and recommend next steps, eliminating hours of manual navigation by delivering instant, explainable insights where reviewers work. * End-to-end RBQM traceability: RACT integration into review objectives plus RBQM Snapshots to preserve evidence over time, improve audit readiness, and strengthen follow-up execution. * Faster, more consistent RBQM setup: Study-level RBQM configuration with linkage to global KRIs/QTLs and the ability to auto-pull KRIs/QTLs from RACT, reducing manual effort and accelerating study startup. * Guided centralized monitoring experience: In-context KRI/QTL/risk signal review - thresholds, recommendations, related observations - directly from the RBQM Overview to drive faster, more consistent decisions. * Agentic SDTM mapping automation from spec to executable code: Automated and agentic-AI-powered specification generation, plus transparent code generation - Python/R/SAS - with traceability from spec through execution logs to accelerate submission-ready datasets. "Insight from clients and partners at ENGAGE 2025 and the data from our 2025 Industry Outlook Survey reaffirmed our conviction of creating a strong data intelligence foundation through the elluminate platform that elicits scalable innovation, from embedding intelligence to risk-based approaches," said Raj Indupuri, CEO and co-founder of eClinical Solutions. "As we look at our next phase of growth, we're hyper-focused on driving return on investment for our clients and leaning into agentic AI in 2026, for the next era of clinical trial automation." About eClinical Solutions LLC eClinical Solutions' industry-leading clinical data intelligence platform, elluminate(R), and biometrics services experts help biopharma researchers at large, mid-size, and emerging life sciences organizations develop tomorrow's breakthroughs with today's resources. eClinical is a privately-held, purpose-driven company with a global workforce and winner of the 2025 Top Workplace USA Award: Remote Work, the 2025 Top Workplaces Culture Excellence Award: Work-Life Flexibility, and Great Place To Work(R) India Certification(TM). Learn more at www.eclinicalsol.com and follow eClinical Solutions on LinkedIn.

Business Wire
Feb 26th, 2026
eClinical Solutions adds 20+ clients including 18 of top 50 pharma firms, launches AI-powered clinical trial platform innovations

eClinical Solutions, a global provider of digital clinical software and services, has added over 20 new customers in 2025, bringing its client portfolio to 18 of the top 50 pharmaceutical companies worldwide. The company evolved its elluminate platform into a clinical data intelligence system, launching elluminate agents powered by AI and a digitised Integrated Data Review Plan. The Boston-based firm received industry recognition in Everest Group's RBQM report and won the 2025 Top Workplace USA Award for Remote Work. For 2026, eClinical Solutions unveiled platform updates including agentic data review automation, end-to-end RBQM traceability, and automated SDTM mapping. The company announced a collaboration with ZS to create an integrated quality risk management experience for sponsors.

HIT Consultant
May 20th, 2025
Cycle Time Is The New Currency Of Drug Development

Raj Indupuri, CEO and Co-Founder of eClinical SolutionsFor years, the life sciences industry has been trying to address the same RD challenges: rising costs, patient recruitment and retention, and difficulty maximizing ROI. Drug development is expensive, and failure rates remain high. Studies estimate the total cost to develop a new drug is between $300 million and nearly $4.5 billion. Meanwhile, clinical trial cycle times continue to lengthen – significantly impacting overall drug development timelines. Clinical trials are increasingly complex, with more complicated protocols and more data collected than ever before. The data points collected in Phase III pivotal trials increased by 283.2% in the decade between 2010 and 2020, according to the Tufts Center for the Study of Drug Development

INACTIVE